跳至主要内容
临床试验/NCT01038102
NCT01038102已完成不适用

Role of Dietary Fatty Acids in Fatty Liver and Insulin Resistance: a Randomized Controlled Study

Uppsala University2 个研究点 分布在 1 个国家目标入组 65 人开始时间: 2009年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
65
试验地点
2
主要终点
Hepatic steatosis by MRT

研究概览

简要总结

The purpose of this study is to investigate whether substituting saturated fats with polyunsaturated fats reduces fatty liver and improves insulin action and other metabolic variables in abdominally obese subjects

详细描述

Specific goals:

  1. Investigate if substituting saturated fats with polyunsaturated fats reduces steatosis and improves hepatic and/or peripheral insulin action in abdominally obese subjects with type 2 diabetes
  2. Investigate if changes of lipogenic enzymes in response to dietary fat intervention are associated with changes in hepatic/peripheral insulin sensitivity or liver fat content
  3. Investigate potential mechanism of the effects of dietary fatty acids; e.g. gene expression and lipogenic enzyme activity

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
30 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • abdominal obese subjects with or without type 2 diabetes
  • sagittal abdominal diameter >25cm

排除标准

  • insulin treatment
  • history of serious cardiovascular events
  • morbid obesity
  • claustrophobia (relative criterion)

结局指标

主要结局

Hepatic steatosis by MRT

时间窗: 10 weeks

次要结局

  • Changes in adipose tissue gene expression and lipogenic enzyme activity(10 weeks)
  • Insulin resistance by oral glucose tolerance test(10 weeks)

研究者

发起方
Uppsala University
申办方类型
Other

研究点 (2)

Loading locations...

相似试验